Patient Report Outcomes Measures clinical trials

Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease

This study looks for new ways to measure Charcot-Marie-Tooth disease type 1A (CMT1A) early on. It involves 35 people with CMT1A and 20 healthy volunteers, aged 10-30, over two years. The goal is to find markers that predict how the disease might progress.